Literature DB >> 22040443

Primary angiitis of the central nervous system: a case report.

Xiao-lin Yu1, Ai-fen Liu, Lin Ma, Chuan-zhu Yan, Yu-ying Zhao, Pei-yan Shan.   

Abstract

Primary angiitis of the central nervous system is a rare and difficult entity. Here we represented the clinical and pathological features of a patient with little response to steroid before definite diagnosis. The 50-year-old male had a fluctuating disease course for more than 3 years. He presented visual disorders, seizure, cognitive impairment, hypersomnia, unsteady gait, dysphasia, dysphagia, and incontinence. Magnetic resonance imaging showed multiple, supratentorial and infratentorial abnormal signals, while cerebrospinal fluid and cerebral angiography were normal. Magnetic resonance spectrum showed a decrease of N-acetyl-aspartate. Brain biopsy revealed nongranulomatous lymphatic vasculitis with reactive gliosis, cicatrization, demyelination and focal hemorrhages.

Entities:  

Mesh:

Year:  2011        PMID: 22040443

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Primary CNS vasculitis masquerading as glioblastoma: A case report and review.

Authors:  Pelluru Pavan Kumar; Alugolu Rajesh; Rukmini Mrudula Kandadai; Aniruddh Kumar Purohit; Challa Sundaram
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

2.  Radial contrast enhancement on brain magnetic resonance imaging diagnostic of primary angiitis of the central nervous system: a case report and review of the literature.

Authors:  Kartheek Ganta; Aisha Mohsin Malik; James B Wood; Michael C Levin
Journal:  J Med Case Rep       Date:  2014-01-27

Review 3.  "When should primary angiitis of the central nervous system (PACNS) be suspected?": literature review and proposal of a preliminary screening algorithm.

Authors:  Cristina Sarti; Antonella Picchioni; Roberta Telese; Marco Pasi; Ylenia Failli; Giovanni Pracucci; Daniele Cammelli; Domenico Inzitari
Journal:  Neurol Sci       Date:  2020-08-10       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.